Zidovudine
In the US, Zidovudine (zidovudine systemic) is a member of the drug class nucleoside reverse transcriptase inhibitors (NRTIs) and is used to treat HIV Infection, Nonoccupational Exposure, Occupational Exposure and Reduction of Perinatal Transmission of HIV.
US matches:
- Zidovudine
- Zidovudine capsules
- Zidovudine syrup
- Zidovudine injection
- Zidovudine Intravenous
- Zidovudine Oral Solution
- Zidovudine Tablets
- Zidovudine (Azidothymidine; AZT; Compound S)
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
J05AF01
CAS registry number (Chemical Abstracts Service)
0030516-87-1
Chemical Formula
C10-H13-N5-O4
Molecular Weight
267
Therapeutic Categories
Antiviral agent
Treatment of HIV infection
Nucleoside reverse transcriptase inhibitor (NRTI)
Chemical Name
3'-azido-3'-deoxythymidine (WHO)
Foreign Names
- Zidovudinum (Latin)
- Zidovudin (German)
- Zidovudine (French)
- Zidovudina (Spanish)
Generic Names
- Zidovudina (OS: DCIT)
- Zidovudine (OS: BAN, JAN, DCF, USAN)
- Azidothymidine (IS)
- AZT (IS: Wellcome)
- BWA 509 U (IS)
- Zidovudine (PH: BP 2011, JP XV, Ph. Eur. 7, Ph. Int. 4, USP 34)
- Zidovudinum (PH: Ph. Eur. 7, Ph. Int. 4)
Brand Names
- 3TC COMPLEX (Zidovudine and Lamivudine)
GlaxoSmithKline, Argentina - 3-TC/AZT ELEA (Zidovudine and Lamivudine)
Elea, Argentina - Adco-Zidovudine
Adcock Ingram Pharmaceuticals, South Africa - Ai Jian
Neptunus, China - Antivir
GPO, Thailand - Apo-Zidovudine
Apotex, Canada; Apotex, Singapore - Aspen Lamzid (Zidovudine and Lamivudine)
Aspen Pharmacare, South Africa - Aspen Zidovudine
Aspen Pharmacare, South Africa - Atazor
Emcure, India - Aviral AZT
Biogen, Colombia - Aviro-Z
Ranbaxy Laboratories, Ethiopia - Avocomb (Zidovudine and Lamivudine)
Ranbaxy Laboratories, Ethiopia - Avudin (Zidovudine and Lamivudine)
Square, Bangladesh - Azidomine
Chung Gei, South Korea - Biovir (Zidovudine and Lamivudine)
GlaxoSmithKline, Brazil - Cipla-Duovir (Zidovudine and Lamivudine)
Cipla Medpro, South Africa - Cipla-Zidovudine
Cipla Medpro, South Africa - Combid (Zidovudine and Lamivudine)
GlaxoSmithKline, Thailand - Combivir (Zidovudine and Lamivudine)
Glaxo, Latvia; Glaxo Group, Luxembourg; Glaxo Group, Poland; Glaxo Wellcome, Slovenia; Glaxo Wellcome, Tunisia; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bahrain; GlaxoSmithKline, Chile; GlaxoSmithKline, China; GlaxoSmithKline, Colombia; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Denmark; GlaxoSmithKline, Spain; GlaxoSmithKline, Ethiopia; GlaxoSmithKline, Finland; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Hungary; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, India; GlaxoSmithKline, Iceland; GlaxoSmithKline, Japan; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Peru; GlaxoSmithKline, Philippines; GlaxoSmithKline, Romania; GlaxoSmithKline, Serbia; GlaxoSmithKline, Russian Federation; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Turkey; GlaxoSmithKline, Taiwan; GlaxoSmithKline, Venezuela; GlaxoSmithKline, South Africa; ViiV, Austria; ViiV, Switzerland; ViiV, United Kingdom; ViiV Healthcare, Germany; ViiV Healthcare, France; ViiV Healthcare, Italy; ViiV Healthcare, Norway; ViiV Healthcare, United States; ViiV Healthcare ULC, Canada; Viivhiv, Portugal; Wellcome, Bosnia & Herzegowina - Crisazet
LKM, Argentina - Cytocom (Zidovudine and Lamivudine)
Alkem, India - Cytocom-N (Zidovudine and Lamivudine, + Zidovudine)
Alkem, India - Diavix (Zidovudine and Lamivudine)
Beximco, Bangladesh - Ding Te
Hisun, China - Duovir (Zidovudine and Lamivudine)
Cipla, Ethiopia; Cipla, India - Duovir-N (Zidovudine and Lamivudine, + Nevirapine)
Cipla, India - Duovox (Zidovudine and Lamivudin)
Biotoscana, Peru - FeiTe
Topfond Pharmaceutical, China - Flamizid
Flamingo Pharmacueticals, Ethiopia - Ganvirel Duo (Zidovudine and Lamivudine)
Ivax, Argentina - He Pu Ren
Hubei Hepu Pharmaceutical Co., Ltd, China - Iduvo
Dosa, Argentina - Jiuli
XinShiDai Pharmaceutical, China - Ke Ai Si
Lifeike Pharmaceutical, China - Kedu
NEGPF, China - Lamda-Z (Zidovudine and Lamivudine)
Cadila, India - Lamivudine and Zidovudine Aurobindo (Zidovudine and Lamivudine)
Aurobindo, United States - Lamivudine and Zidovudine Lupin (Zidovudine and Lamivudine)
Lupin, United States - Lamivudine and Zidovudine Teva (Zidovudine and Lamivudine)
Teva, United States - Lamiwudyna/Zydowudyna Mylan (Zidovudine and Lamivudine)
Mylan, Poland - Lamuzid (Zidovudine and Lamivudine)
Cadila Health Care, Ethiopia; Zydus, India; Zydus Cadila, Myanmar - Lamzidivir (Zidovudine and Lamivudine)
Stada-VN JV, Vietnam - Lamzitrio (Zidovudine and Nevirapine, + Lamivudine)
Stada-VN JV, Vietnam - Lasovir (Zidovudine and Lamivudine)
Zifam India, Myanmar - Lazid (Zidovudine and Lamivudine)
Emcure, India - Lazid-N (Zidovudine and Lamivudine, + Nevirapine)
Emcure, India - Lazivir (Zidovudine and Lamivudine)
Celon, Poland - Medivir (Zidovudine and Lamivudine)
Meditab, Myanmar - Na Xin De
Qilu, China - Pu Xi Ding
Shyndec, China - Qi Luo Ke
Meijisi Pharmaceutical, China - Retrocar
Refasa, Peru - Retrovir
Glaxo Wellcome, Portugal; GlaxoSmithKline, Argentina; GlaxoSmithKline, Austria; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Bulgaria; GlaxoSmithKline, Brazil; GlaxoSmithKline, Chile; GlaxoSmithKline, China; GlaxoSmithKline, Colombia; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Denmark; GlaxoSmithKline, Estonia; GlaxoSmithKline, Spain; GlaxoSmithKline, Ethiopia; GlaxoSmithKline, Finland; GlaxoSmithKline, Georgia; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Hungary; GlaxoSmithKline, Indonesia; GlaxoSmithKline, Israel; GlaxoSmithKline, India; GlaxoSmithKline, Iceland; GlaxoSmithKline, Japan; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Luxembourg; GlaxoSmithKline, Latvia; GlaxoSmithKline, Malta; GlaxoSmithKline, Malaysia; GlaxoSmithKline, New Zealand; GlaxoSmithKline, Oman; GlaxoSmithKline, Peru; GlaxoSmithKline, Poland; GlaxoSmithKline, Romania; GlaxoSmithKline, Sweden; GlaxoSmithKline, Singapore; GlaxoSmithKline, Slovakia; GlaxoSmithKline, Thailand; GlaxoSmithKline, Tunisia; GlaxoSmithKline, Turkey; GlaxoSmithKline, Taiwan; GlaxoSmithKline, Venezuela; GlaxoSmithKline, South Africa; P & D, Malta; ViiV, United Kingdom; ViiV, Netherlands; ViiV Healthcare, Germany; ViiV Healthcare, France; ViiV Healthcare, Norway; ViiV Healthcare, United States; Wellcome, Ireland; Wellcome-GB, Italy - Retrovir (AZT)
ViiV Healthcare ULC, Canada - Retrovir AZT
GlaxoSmithKline, Mexico; ViiV, Switzerland - Revirax
Blausiegel, Brazil - Sonke-Lamivudine + Zidovudine (Zidovudine and Lamivudine)
Ranbaxy, South Africa - Sonke-Zidovudine
Ranbaxy, South Africa - T.O.Vir
TO Chemicals, Thailand - Tivizid (Zidovudine and Lamivudine + Abacavir)
Square, Bangladesh - Triovix (Zidovudine and Lamivudine + Nevirapine)
Beximco, Bangladesh - Trizivir (Zidovudine and Abacavir, + Lamivudine)
Glaxo Wellcome, Serbia; GlaxoGroup, Netherlands; GlaxoSmithKline, Australia; GlaxoSmithKline, Belgium; GlaxoSmithKline, Canada; GlaxoSmithKline, China; GlaxoSmithKline, Colombia; GlaxoSmithKline, Czech Republic; GlaxoSmithKline, Germany; GlaxoSmithKline, Spain; GlaxoSmithKline, Finland; GlaxoSmithKline, Georgia; GlaxoSmithKline, Greece; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Ireland; GlaxoSmithKline, Israel; GlaxoSmithKline, Iceland; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Mexico; GlaxoSmithKline, Norway; GlaxoSmithKline, Oman; GlaxoSmithKline, Romania; GlaxoSmithKline, Sweden; GlaxoSmithKline, Turkey; GlaxoSmithKline, Taiwan; GlaxoSmithKline, South Africa; Novo Nordisk, Denmark; Shire, Canada; ViiV, Austria; ViiV, Switzerland; ViiV, United Kingdom; ViiV Healthcare, France; ViiV Healthcare, Italy; ViiV Healthcare, United States; Viivhiv, Portugal - Trovir (Zidovudine and Lamivudine, + Nevirapine)
Zifam India, Myanmar - T-ZA
Siam Bheasach, Thailand - Virdual (Zidovudine and Lamivudine)
Biogen, Colombia - Viro-Z
Ranbaxy, India - Viroclon
Medicus, Greece - Virocomb (Zidovudine and Lamivudine)
Ranbaxy, India; Ranbaxy, Myanmar - Virocomb-N (Zidovudine and Lamivudine, + Nevirapine)
Ranbaxy, India; Ranbaxy, Myanmar - Wei Nuo
Fenghuang Pharmaceutical, China - Zetrotax
Richmond, Argentina - Zidine
Emcure, India; Emcure, Myanmar - Zido-H
Hetero, Georgia - Zidomax
Alkem, India - Zidosan
Slaviamed, Serbia - Zidovex
Aurobindo, Ethiopia - Zidovir
Cipla, Ethiopia; Cipla, Georgia; Cipla, India; Pharmaceutical, Venezuela - Zidovudin Aurobindo
Aurobindo, Germany - Zidovudin Stada
Stada-VN JV, Vietnam - Zidovudina Biomendi
Biomendi, Spain - Zidovudina Combino Pharm
Combino, Spain - Zidovudina Filaxis
Filaxis, Argentina - Zidovudina Generis
Generis, Portugal - Zidovudina GES
Ges Genericos, Spain - Zidovudina
Combino Pharm, Tunisia; Iqfarma, Peru - Zidovudine Aurobindo
Aurobindo, United States - Zidovudine Cipla
Cipla, United States - Zidovudine GMP
Giempi, Venezuela - Zidovudine Hec Pharm
Hec Pharm, United States - Zidovudine Hetero
Hetero, United States - Zidovudine Luitpold
Luitpold, United States - Zidovudine Matrix
Matrix, United States - Zidovudine Roxane
Roxane, United States - Zidovudine
Aurobindo, Malta - Zidox
Biotoscana, Peru - Zorpex
Ranbaxy, China - Zudon
Medibios Laboratories, Ethiopia - Zydowin
Cadila Health Care, Ethiopia; Zydus, India
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| USAN | United States Adopted Name |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.


